{
    "name": "zinc",
    "comment": "Rx, OTC",
    "other_names": [
        "Galzin",
        "ZnCl2"
    ],
    "classes": [
        "Trace Elements/Metals"
    ],
    "source": "https://reference.medscape.com/drug/galzin-zinc-344449",
    "pregnancy": {
        "common": [
            "Pregnancy Category: A (Galzin); C (injction or gluconate)",
            "Lactation: Present in breast milk, use caution"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: Present in breast milk, use caution"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Not for direct injection into peripheral vein (may cause infusion phlebitis)",
                "Injection contains aluminum, which may cause toxicity in prolonged parenteral administration if renal function impaired",
                "Do not use zinc intranasally (as in Zicam)-risk of permanent loss of smell",
                "Lozenges sweetened with citric acid, mannitol, or sorbitol have decreased efficacy; should only be sweetened with glycine"
            ],
            "specific": [
                {
                    "type": "Wilson disease",
                    "description": [
                        "Not recommended for initial therapy of symptomatic patients with because of the delay required for zinc-induced increase in enlerolyhc metallothionein and blockade of copper uptake; may be used as maintenance therapy after patient has stabilized on initial chelation therapy",
                        "Symptomatic patients should be treated initially, using chelating agents for initial therapy; neurological deterioration may occur as copper stores are mobilized"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Nausea",
            "percent": "1-2"
        },
        {
            "name": "vomiting",
            "percent": null
        },
        {
            "name": "Gastric irritation",
            "percent": null
        },
        {
            "name": "Elevations of serum alkaline phosphatase",
            "percent": null
        },
        {
            "name": "amylase",
            "percent": null
        },
        {
            "name": "and lipase that may return to high normal within",
            "percent": null
        },
        {
            "name": "years of therapy",
            "percent": null
        },
        {
            "name": "Neurologic deterioration",
            "percent": null
        }
    ]
}